Jade Biosciences Announces Quarterly Results for June 30, 2026

What Happened
Jade Biosciences, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release issued on August 10, 2026. The company furnished that press release as Exhibit 99.1 to its Current Report on Form 8-K (filed Aug 10, 2026) reporting results of operations and financial condition.

Key Details

• Announcement date: August 10, 2026.
• Reporting period: quarter ended June 30, 2026.
• Disclosure vehicle: press release furnished as Exhibit 99.1 to the Form 8-K.
• The filing also includes the cover page interactive data file (inline XBRL) per the exhibit index.

Why It Matters
This 8-K is Jade Biosciences’ official disclosure of its recent quarterly earnings information. Investors should review the attached press release for the company’s reported revenue, earnings (or losses), cash position, and any management commentary or forward-looking statements that could affect the stock. The filing itself confirms the company has publicly released its quarterly results and that detailed financial metrics are available in the press release (Exhibit 99.1).